Is Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy a Safe and Effective Procedure for Treating Patients With a Peritoneal Surface Malignancy?
作者信息
Park Dong-Guk
机构信息
Department of Surgery, Dankook University College of Medicine, Cheonan, Korea.
出版信息
Ann Coloproctol. 2017 Feb;33(1):3-4. doi: 10.3393/ac.2017.33.1.3. Epub 2017 Feb 28.
Abstract
摘要
相似文献
1
Is Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy a Safe and Effective Procedure for Treating Patients With a Peritoneal Surface Malignancy?细胞减灭术和腹腔内热灌注化疗是治疗腹膜表面恶性肿瘤患者的安全有效方法吗？
Ann Coloproctol. 2017 Feb;33(1):3-4. doi: 10.3393/ac.2017.33.1.3. Epub 2017 Feb 28.
2
Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.根治性细胞减灭术和腹腔内热灌注化疗治疗阑尾来源的假性黏液瘤腹膜假性黏液瘤的可行性。
Scand J Surg. 2013;102(3):145-51. doi: 10.1177/1457496913490463.
3
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.接受细胞减灭术和腹腔内热灌注化疗的结直肠癌腹膜转移患者全身化疗的时机
Dis Colon Rectum. 2017 May;60(5):477-487. doi: 10.1097/DCR.0000000000000774.
4
Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.结直肠腹膜转移的细胞减灭术和腹腔热灌注化疗的演变：8 年单中心经验。
Dis Colon Rectum. 2019 Oct;62(10):1195-1203. doi: 10.1097/DCR.0000000000001456.
5
Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.在接受预防性细胞减灭术和腹腔内热灌注化疗的高级别阑尾肿瘤患者中，腹膜受累比淋巴结受累更常见。
Dis Colon Rectum. 2017 Nov;60(11):1155-1161. doi: 10.1097/DCR.0000000000000869.
6
7
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.细胞减灭术和腹腔内热灌注化疗联合全身化疗与单纯全身化疗治疗结直肠腹膜转移癌的比较。
Cancer. 2010 Aug 15;116(16):3756-62. doi: 10.1002/cncr.25116.
8
Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.结直肠或阑尾肿瘤所致腹膜表面恶性肿瘤患者的细胞减灭术及腹腔内热灌注化疗应用指南。
Curr Oncol. 2015 Apr;22(2):e100-12. doi: 10.3747/co.22.2058.
9
Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.减瘤手术及热灌注化疗后腹壁并发症
Scand J Surg. 2017 Dec;106(4):294-298. doi: 10.1177/1457496917690989. Epub 2017 Mar 1.
10
Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions.
Ann Surg Oncol. 2005 Oct;12(10):765-77. doi: 10.1245/ASO.2005.12.001. Epub 2005 Aug 18.
引用本文的文献
1
Albumin Leakage Level during Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Associated with Major Complications.减瘤手术及热灌注化疗期间白蛋白渗漏水平与主要并发症相关。
Cancers (Basel). 2024 Aug 19;16(16):2874. doi: 10.3390/cancers16162874.
本文引用的文献
1
Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy.热灌注腹腔化疗的单中心经验
Ann Coloproctol. 2017 Feb;33(1):16-22. doi: 10.3393/ac.2017.33.1.16. Epub 2017 Feb 28.
2
Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer: 2-year follow-up results at a single institution in Korea.结直肠癌腹膜转移癌的细胞减灭术及腹腔内化疗：韩国一家机构的2年随访结果
Ann Surg Treat Res. 2016 Oct;91(4):157-164. doi: 10.4174/astr.2016.91.4.157. Epub 2016 Sep 30.
3
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality.肿瘤细胞减灭术及腹腔热灌注化疗：对发病和死亡相关因素的综述
J Gastrointest Oncol. 2016 Feb;7(1):99-111. doi: 10.3978/j.issn.2078-6891.2015.100.
4
Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies.腹膜恶性肿瘤细胞减灭术及腹腔热灌注化疗的机构学习曲线
Ann Surg Oncol. 2015 May;22(5):1673-9. doi: 10.1245/s10434-014-4111-x. Epub 2014 Nov 7.
5
Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement.细胞减灭术及腹腔内热灌注化疗对伴有膈肌受累患者的疗效
Ann Surg Oncol. 2015 May;22(5):1639-44. doi: 10.1245/s10434-014-4083-x. Epub 2014 Sep 13.
6
Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP database.细胞减灭术联合腹腔内化疗的发病率和死亡率：来自美国外科医师学会国家外科质量改进计划（ACS NSQIP）数据库的结果
Ann Surg Oncol. 2014 May;21(5):1494-500. doi: 10.1245/s10434-013-3223-z. Epub 2013 Aug 29.
Zotero 插件